---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-25-000172"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2025-11-26T23:59:59+00:00"
generated_at: "2026-05-16T16:29:29.358479+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Recursion issues 7.1M shares to Tempus AI for license fees; registers for resale

## Summary
- Issued 7,088,742 Class A shares to Tempus AI on Nov 24, 2025 as payment for annual license fees.
- Shares registered for resale via prospectus supplement filed Nov 26, 2025 under existing shelf registration.
- Issuance stems from Master Agreement dated Nov 9, 2023, as previously disclosed in an 8-K.
- Resale registration may allow Tempus to sell shares, creating potential dilution for existing holders.

## SEC filing metadata
- accession: 0001601830-25-000172
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2025-11-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000172/0001601830-25-000172-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000172/rxrx-20251126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-25-000172
- JSON: https://secwatch.observer/filing/0001601830-25-000172.json
- Plain text: https://secwatch.observer/filing/0001601830-25-000172.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.